Platinum-resistant Epithelial Ovarian Cancer

DrugDrug NameDrug Description
DB01101CapecitabineA nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.
DB12489Mirvetuximab soravtansineA folate receptor alpha-directed antibody and microtubule inhibitor conjugate used to treat folate receptor alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
DrugDrug NamePhaseStatusCount
DB00997Doxorubicin1Terminated1
DB09037Pembrolizumab1Terminated1
DB01611Hydroxychloroquine1 / 2Completed1
DB01167Itraconazole1 / 2Completed1
DB00531Cyclophosphamide2Terminated1
DB17339Maveropepimut-S2Terminated1